Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Novel oxytocin derivative can reverse Aβ25-35-induced cognitive impairment in mice

Alzheimer's disease (AD), characterized by an accumulation of β-amyloid protein (Aβ) in brain tissue, is a leading cause of dementia.

24 Oct 2022

Low meal frequency is suggested to decrease Alzheimer’s disease risk

Researchers evaluated the associations between low meal frequency (LMF) and Alzheimer’s disease (AD).

24 Oct 2022

TDP-43 can be useful biomarker for identifying neuropathological subtypes of frontotemporal dementia

Frontotemporal dementia (FTD) is one of the most common causes of progressive dementia in working-age people.

20 Oct 2022

Family caregivers find support on #dementia TikTok

It all changed on a Saturday night in New York City in 2016. Jacquelyn Revere was 29 and headed out to attend a friend’s comedy show. She was on the subway when her phone rang.

20 Oct 2022

Weight change in the early stages of Parkinson's disease may be linked with changes in thinking skills

People who gain or lose weight soon after being diagnosed with Parkinson's disease may be more likely to have changes in their thinking skills than people who maintain their weight, according to a study published in the October 19, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Oct 2022

Salk's three collaborative projects win 2022 Curebound Discovery Grant

The Salk Institute's American Cancer Society Professor Tony Hunter, Professor Reuben Shaw, and Assistant Professor Graham McVicker are among 12 inaugural 2022 Discovery Grant winners.

19 Oct 2022

Researchers develop a powerful computational tool for understanding brain health and disease

A team led by researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, in close collaboration with investigators at Mass General Hospital and Beth Israel Deaconess Medical Center has developed a powerful computational tool for understanding brain health and disease, providing an enhanced way of characterizing the activity of the brain during sleep.

18 Oct 2022

People with end-stage renal disease and psoriasis do not have increased risk for heart attack

Studies have suggested that psoriasis is an independent risk factor for heart attack in the general population, but investigators have made the surprising finding that in people who also have end-stage renal disease, which shares many risk factors with heart disease, it is not.

18 Oct 2022

UTA engineer will use deep-learning tools to pinpoint types of Alzheimer's disease-related dementias

A University of Texas at Arlington computer science engineer will advance and integrate powerful deep-learning methods and tools to pinpoint types of Alzheimer's disease-related dementias (ADRD), which in turn could help the medical community better treat those diseases.

17 Oct 2022

Newly identified brain molecule orchestrates the immune system's responses to Alzheimer's and MS

UVA Health researchers have discovered a molecule in the brain responsible for orchestrating the immune system's responses to Alzheimer's disease and multiple sclerosis (MS), potentially allowing doctors to supercharge the body's ability to fight those and other devastating neurological diseases.

17 Oct 2022

Timely treatment of depression could reduce the risk of dementia

Depression has long been associated with an increased risk of dementia, and now a new study provides evidence that timely treatment of depression could lower the risk of dementia in specific groups of patients.

17 Oct 2022

Study reveals why viral infections are less frequent but more severe in individuals with Down syndrome

Individuals with Down syndrome have less-frequent viral infections, but when present, these infections lead to more severe disease.

14 Oct 2022

Over £800 million to support improved healthcare delivery and breakthroughs in new treatments

Patients up and down the country are set to benefit from innovative new treatments and improved delivery of health and care services following significant funding to support ground-breaking experimental medicine research and advance the UK's response to patient safety challenges.

14 Oct 2022

SARS-CoV-2 causes neuronal damage and inflammation within a week of infection in rhesus macaques

SARS-CoV-2, the COVID-19 virus, caused significant neuron damage and inflammation within a week of infection in rhesus macaque monkeys, according to a new study.

14 Oct 2022

Researchers explore sex/gender differences in cognitive abilities and verbal fluency

"Women are better. The female advantage is consistent across time and life span, but it is also relatively small", says Marco Hirnstein, professor at The University of Bergen, Norway.

14 Oct 2022

Mouse model reveals how RNA splicing defects contribute to neurodegeneration in Alzheimer's disease

Researchers have puzzled over the neurodegenerative disorder Alzheimer's disease for decades, but treatments to stop or reverse the disease's effects on the brain have remained elusive.

13 Oct 2022

Enterin and Parkinson's Virtual Biotech collaborate to study the effects of ENT-01 on PD-associated dementia

Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company developing novel treatments for neurodegenerative and metabolic diseases announces a collaboration with the Parkinson's Virtual Biotech, the drug development and discovery arm of Parkinson's UK.

13 Oct 2022

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Novel oxytocin derivative can reverse Aβ25-35-induced cognitive impairment in mice

Low meal frequency is suggested to decrease Alzheimer’s disease risk

TDP-43 can be useful biomarker for identifying neuropathological subtypes of frontotemporal dementia

Family caregivers find support on #dementia TikTok

Weight change in the early stages of Parkinson's disease may be linked with changes in thinking skills

Salk's three collaborative projects win 2022 Curebound Discovery Grant

Researchers develop a powerful computational tool for understanding brain health and disease

People with end-stage renal disease and psoriasis do not have increased risk for heart attack

UTA engineer will use deep-learning tools to pinpoint types of Alzheimer's disease-related dementias

Newly identified brain molecule orchestrates the immune system's responses to Alzheimer's and MS

Timely treatment of depression could reduce the risk of dementia

Study reveals why viral infections are less frequent but more severe in individuals with Down syndrome

Over £800 million to support improved healthcare delivery and breakthroughs in new treatments

SARS-CoV-2 causes neuronal damage and inflammation within a week of infection in rhesus macaques

Researchers explore sex/gender differences in cognitive abilities and verbal fluency

Mouse model reveals how RNA splicing defects contribute to neurodegeneration in Alzheimer's disease

Enterin and Parkinson's Virtual Biotech collaborate to study the effects of ENT-01 on PD-associated dementia

New findings highlight the need for strategies to mitigate widening disparities in mortality rates

Diets not linked to reduced risk of dementia, study finds

Grants to shed light on caregiving for Alzheimer's patients in Filipino communities

Aneuro: An Overview of Neuroscience Research eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Aneuro: An Overview of Neuroscience Research eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in